Health Status Prior and Post Infection With Influenza or COVID 19: a Population Based Retrospective Analysis of 2016-2021
October 22, 2021 updated by: Hendrik Jan Ankersmit, Medical University of Vienna
The overall project aim is to study outcomes after COVID-19 and influenza hospitalisation from 2016 - 2021 by retrieving data from the main social security carriers in Austria for the years 2010-2018
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
440000
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All patients with or after Covid-19 or influenza between 2016-2021 in Austria will be included in this study
Description
Inclusion Criteria:
- Patients with SARS
- Patients with Covid-19
- Patients after Covid-19
- Patients with influenza
Exclusion Criteria:
- none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Influenza
|
PCR or antigen test for Covid 19 or Inluenza
|
|
Covid 19
|
PCR or antigen test for Covid 19 or Inluenza
|
|
Control group
hospitalisation due to other disease (not influenza or Covid 19)
|
PCR or antigen test for Covid 19 or Inluenza
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall Mortality
Time Frame: 5 years
|
Overall mortality after influenza or covid-19
|
5 years
|
|
age distribution
Time Frame: 5 years
|
age distribution in patients with influenza or covid-19
|
5 years
|
|
risk profile
Time Frame: 5 years
|
risk profile (e.g.
prior diseases, medication) in patients who died due to influenza or covid-19
|
5 years
|
|
newly diagnosed diseases
Time Frame: 5 years
|
newly diagnosed diseases after influenza or covid-19
|
5 years
|
|
newly prescribed medication
Time Frame: 5 years
|
newly prescribed medication after influenza or covid-19
|
5 years
|
|
duration of hospitalisation or unemployability
Time Frame: 5 years
|
duration of hospitalisation or unemployability after influenza or covid-19
|
5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 1, 2016
Primary Completion (ACTUAL)
August 31, 2021
Study Completion (ACTUAL)
August 31, 2021
Study Registration Dates
First Submitted
October 19, 2021
First Submitted That Met QC Criteria
October 19, 2021
First Posted (ACTUAL)
October 21, 2021
Study Record Updates
Last Update Posted (ACTUAL)
October 29, 2021
Last Update Submitted That Met QC Criteria
October 22, 2021
Last Verified
October 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AUTCOV-INFLU-STUDY
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.